P/FCF Ratio for Climb Bio (CLYM)

Climb Bio (CLYM) P/FCF ratio is 2651.6× as of September 27, 2024. The 5-year average is 4169.1×. The sector median currently stands at 19.7×. The current ratio is at the 3th percentile of its own 10-year history.

Climb Bio (CLYM) historical P/FCF ratio has ranged from a low of 2651.6× (2024) to a high of 4504.5× (2024) in the available daily series.

The price-to-free-cash-flow (P/FCF) ratio compares a company's market capitalisation to its trailing twelve-month (TTM) free cash flow. It is calculated as market cap ÷ TTM free cash flow, where free cash flow = operating cash flow − capital expenditures. Because FCF cannot be inflated by non-cash accounting items, P/FCF is often considered a cleaner measure of "earnings-power valuation" than P/E — especially for capital-intensive businesses where depreciation diverges from real cash outflows.